SCHEMBL17295436

SCHEMBL17295436

Cn1ncc2cc(C=C3SC(=Nc4ccccc4)N(c4ccccc4)C3=O)ccc21

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 3/20 0.59
▸ MEN1 O00255 4/20 0.58
▸ ALDH1A1 P00352 4/20 0.58
▸ KMT2A Q03164 4/20 0.58
▸ NPSR1 Q6W5P4 1/20 0.58
▸ LMNA P02545 2/20 0.53
▸ MAPT P10636 1/20 0.53
▸ CYP1A2 P05177 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ S1PR1 P21453 10/20 0.48
▸ S1PR3 Q99500 10/20 0.48
▸ AURKA O14965 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17295434 1.00 FAAH (0.59) FAAHMEN1ALDH1A1KMT2ANPSR1
SCHEMBL17295607 0.85 FAAH (0.55) FAAHMEN1ALDH1A1KMT2ANPSR1
SCHEMBL17295605 0.85 FAAH (0.55) FAAHMEN1ALDH1A1KMT2ANPSR1
SCHEMBL24201201 0.80 LMNA (0.42) FAAHMEN1ALDH1A1KMT2ANPSR1
SCHEMBL17295357 0.79 FAAH (0.60) FAAHMEN1ALDH1A1KMT2ANPSR1
SCHEMBL17302238 0.79 FAAH (0.60) FAAHMEN1ALDH1A1KMT2ANPSR1
SCHEMBL17295358 0.79 FAAH (0.60) FAAHMEN1ALDH1A1KMT2ANPSR1
SCHEMBL17309290 0.78 MEN1 (0.79) FAAHMEN1ALDH1A1KMT2ANPSR1
SCHEMBL11331666 0.78 MEN1 (0.79) FAAHMEN1ALDH1A1KMT2ANPSR1
SCHEMBL12013235 0.78 MEN1 (0.79) FAAHMEN1ALDH1A1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148990-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2017-04-05 — — EP disclosed
WO-2015181337-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback